This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Mitsubishi Tanabe Pharma Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Hitoshi Izaki: Pharmaceutical Invention for ME/CFS and Fibromyalgia.
Introduction
Hitoshi Izaki is an inventor associated with Osaka, Japan, and Mitsubishi Tanabe Pharma Corporation. His patent work includes a proposed therapeutic agent for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and fibromyalgia.
Latest Patents
Izaki is credited with 1 patent: “Therapeutic agent for myalgic encephalomyelitis/chronic fatigue syndrome.” The invention describes a therapeutic agent for ME/CFS or fibromyalgia containing 2-amino-2-[2-(4-heptyloxy-3-trifluoromethylphenyl)ethyl]propane-1,3-diol, or a pharmaceutically acceptable salt of that compound.
Career Highlights
Izaki’s listed patent reflects pharmaceutical research focused on potential treatments for ME/CFS and fibromyalgia. He is associated with Mitsubishi Tanabe Pharma Corporation.
Collaborations
Yoshiari Yanai and Rikako Hayashi are identified as Izaki’s coworkers.
Conclusion
Hitoshi Izaki’s patent activity is represented by a pharmaceutical invention proposing a therapeutic agent for ME/CFS and fibromyalgia.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile